SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Genaissance Pharmaceuticals (GNSC)
An SI Board Since September 2000
Posts SubjectMarks Bans Symbol
183 6 0 GNSC
Emcee:  Jim Oravetz Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
83Atherosclerosis 2002 Apr;161(2):469-74 Related Articles, Books, LinkOut A prmichael_f_murphy-4/10/2002
82Clin Genet 2001 Nov;60(5):374-80 Lack of association of the common TaqIB polymmichael_f_murphy-4/10/2002
81Eur J Clin Invest 2001 Jul;31(7):593-602 Comment in: Eur J Clin Invest. 2001 Jscaram(o)uche-4/10/2002
80last prospectus...... Morgan Stanley Dean Witter & Co. (5) ................scaram(o)uche-4/10/2002
79I'll get busy on it. Meanwhile....... SECURITIES AND EXCHANGE COMMISSION scaram(o)uche-4/10/2002
78(Forthcoming) Haplotypes of CETP Predict Clinical Response to Statins Officialmichael_f_murphy-4/10/2002
77Genaissance Finds Genetic Markers That Could Indicate Drug Efficacy By GEETA ANAJim Oravetz-3/27/2002
76About a year is what I was thinking. Off-the-hip guess. FDA will always lobby scaram(o)uche-3/27/2002
75>>right up to the end there, that was a classic (good classic) post.<&ltuck-3/27/2002
74<i>At this point, I haven't enough info to judge whether or not this wscaram(o)uche-3/27/2002
73right up to the end there, that was a classic (good classic) post. I spelled ouscaram(o)uche-3/27/2002
72Hhmmm, doesn't that mean that they'll need to do more specific trials wituck-3/27/2002
71>> Since that PR won the vagueness award << I've been working escaram(o)uche-3/27/2002
70>> Computational approaches alone are probably not going to fly << scaram(o)uche-3/26/2002
69Rick, This article contains a smidgen of color on GNSC's informatics for hatuck-3/26/2002
68Since that PR won the vagueness award, I sold my position at $2.85 for a small ptuck-3/26/2002
67<i>Just don't know what it means, real-world</i> Trading volumenigel bates-3/26/2002
66Interesting...... sounds like results that could be rather VGNX-like? <i&scaram(o)uche-3/26/2002
65GNSC Press Release: >> Genaissance Pharmaceuticals Discovers Genetic MarRCMac-3/26/2002
64Thanks! (eom)scaram(o)uche-3/25/2002
63Hi Rick, Brean Murray can be found at bmur.com All they require is name and emtom rusnak-3/25/2002
62<i>Genaissance Pharmaceuticals plans to use these results in several ways,scaram(o)uche-3/25/2002
61<i>Brean Murray analyst James Murray doesn't think the share rise willscaram(o)uche-3/25/2002
60=DJ Genaissance Up-2: To Release Preliminary Data Tue Or Wed By Beth M. MantzWard Knutson-3/25/2002
59*DJ Genaissance Up 10% On Tailored Medicine Story In WSJ>GNSC (MORE) DOW Ward Knutson-3/25/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News